GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
N

NXT Nutritionals Holdings NXTH · USD

Consumer Staples · US listing · 🇺🇸 United States

Compare

0.00

—

Close of 28 Oct 2026, in USD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

About NXT Nutritionals Holdings

Its shares trade under the ticker NXTH. It has been listed since 25 March 2008. In the fiscal year to 31 December 2011, it reported revenue of $237,989 and a net loss of $1.3m. At that date it held total assets of $515,303 and shareholders' equity of −$11.8m.

NXT Nutritionals Holdings, Inc. engages in the development and marketing of proprietary, patent-pending sweeteners, food, and beverage products. The company is headquartered in Springfield, Massachusetts. The company went IPO on 2008-03-25. Operating through NXT Nutritionals, Inc. (NXT Nutritionals), the Company is engaged in developing and marketing of all-natural, healthy sweetener sold under the brand name SUSTA and other food and beverage products. SUSTA is being sold as a separate product and it is the common ingredient for all of its products. The company also markets and sells Healthy Dairy non-fat yogurt smoothies, which are enhanced by the taste and nutritious ingredients contained in SUSTA. SUSTA is an all natural, healthy sweetener that has minimal calories and low glycemic index. The company is a blend of inulin fiber, fructose, botanical extracts, natural flavors, vitamins, minerals, and probiotics that is patented in New Zealand and patent-pending in the United States and Canada. The firm has developed a line of SUSTA non-fat reduced-calorie yogurt smoothies, which are marketed as Healthy Dairy.

Figures and description from our data supplier, not checked against the company's own report.

Company facts

Sector
Consumer Staples
Industry
Personal Care Products
Listed since
25 Mar 2008

Leadership

Pay as last reported

  • Francis McCarthyPresident, Chief Executive Officer, Secretary, Director, since 2009$438,680
  • David BrionesChief Financial Officer$72,000
  • Mark GiresiChief Operating Officer, General Counsel, Director, since 2009$630,280
  • Richard JordanExecutive Vice President, General Manager, Director, since 2009
  • Dr. Paul AuerbachDirector
  • David DenoDirector
  • Theodore MandesDirector
  • Ann McBrienDirector
  • Philip SheibleyDirector

Environmental, social and governance

Scores out of 100, from our data supplier

ESG
Overall
0
Environment
0
Social
0
Governance
0

SWOT analysis

AI-generated by our data supplier. Not written or checked by our editors.

AI-generated

Strengths

  • SUSTA is an all-natural sweetener with minimal calories and a low glycemic index.
  • The company holds a patent for SUSTA in New Zealand and pending status in the US.
  • SUSTA serves as the common ingredient for all food and beverage products developed by the firm.

Weaknesses

  • The company is headquartered in Springfield, Massachusetts, which may limit immediate global market reach.
  • The IPO occurred on 25 March 2008, indicating a long history without recent capital infusion details.
  • Patent-pending status in the United States and Canada leaves intellectual property protection incomplete in key markets.

Opportunities

  • Healthy Dairy non-fat yogurt smoothies can expand market share by leveraging the nutritious SUSTA ingredient.
  • Patent-pending status in Canada offers potential for future exclusive distribution rights in the Canadian market.
  • Growing consumer demand for low-calorie sweeteners supports the marketing of SUSTA as a healthy alternative.

Threats

  • Competitors may introduce similar all-natural sweeteners with lower glycemic indices, challenging SUSTA's unique selling proposition.
  • Changes in New Zealand patent laws could affect the validity of the existing SUSTA patent.
  • Economic downturns might reduce consumer spending on premium healthy dairy products and specialty sweeteners.

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.